Clinical Trials Logo
  1. Home
  2. Vascular Access Complication
  3. NCT05894317
  4. Details
NCT05894317 Clinical Trial

Vascular Access Complications for Therapeutic Apheresis in Nephrology

Vascular Access Complication Clinical Trial

— VACTANE  

Official title:
Vascular Access Complications for Therapeutic Apheresis in Nephrology : a Retrospective Observational Study in North-East France.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05894317
Other study ID # VACTANE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2020
Est. completion date November 30, 2023

Study information
Verified date May 2023
Source Central Hospital, Nancy, France
Contact Asma Alla, MD
Phone +33 3 83153164
Email a.alla@chru-nancy.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.

Description:

The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology. Complications may include arterio-veinous fistula or graft (AVF or AVG) thrombosis with or without known stenosis; AVF or AVG or central veinous catheter (CVC) infections and CVC dysfunctions. We may enroll all patients receveing therapeutic apheresis for nephrologic indications in our unit: Nephrologics complications include : - acute or active antibody mediated rejection (ABMR), - Goodpasture disease, - ANCA vasculitis, - thrombotic angiopathy (TMA), - Focal segmental glomerulosclerosis (FSGS), - HLA or ABO desensitization for kidney transplantation. Data inclusion period is from June 2020 to June 2022. The aim of the study is to describe the proportion and type of complication in our population of patient receving therapeutic apheresis. We will study the risk factors that are associated with this complications. The second aim of the study is to describe the population of patient receving therapeutic apheresis in our unit and in our region.

Recruitment information / eligibility
Status Recruiting
Enrollment 60
Est. completion date November 30, 2023
Est. primary completion date June 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients in nephrology receiveing apheresis treatment by filtration or double filtration Exclusion Criteria: - apheresis treatment for other indications - centrifugation apheresis treatment

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Central Hospital Nancy

Sponsors (1)
Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Vascular access Complication rate in therapeutic apheresis % of patient with Vascular access Complication june 2020 june 2022
Secondary Description of population enrolled Description of population treated by therapeutic apheresis in Northeast France june 2020 june 2022
Secondary Comparison of complications rate with literature datas june 2020 june 2022
See also
  Status Clinical Trial Phase
Withdrawn NCT04136561 - Novel Strategy to Encourage Early Removal of Central Venous Catheters N/A
Active, not recruiting NCT04054128 - Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients Phase 4
Completed NCT02297308 - A Retrospective Study Evaluating the Use of the SoloPath® Sheath in Reducing Vascular and Bleeding Complications N/A
Completed NCT01446263 - RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial Phase 3
Recruiting NCT05132712 - Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial Early Phase 1
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Completed NCT02200458 - Near-infrared Software Performance Study N/A
Recruiting NCT06001827 - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study N/A
Recruiting NCT04077762 - Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) N/A
Completed NCT05982366 - Feasibility and Safety of the Routine Distal Transradial Approach N/A
Completed NCT05101720 - Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI TRIAL N/A
Terminated NCT03879824 - Radial Versus Femoral Secondary Access During TAVI N/A
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Completed NCT05093699 - Dual-plane Ultrasound Imaging During Vascular Access Procedures N/A
Recruiting NCT02449798 - Prospective Feasibility Trial of AccuCath 2.25" BC Placed in Difficult Access Patients in the Emergency Department N/A
Active, not recruiting NCT02808208 - Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure Phase 1/Phase 2
Completed NCT04409418 - Blood Sampling Functionality of Extended Dwell Catheters N/A
Recruiting NCT04472221 - Arterio-arterial Vascular Access as a Novel Technique for Treatment of Venous Hypertention With Arterio-venous Vascular Access N/A
Completed NCT02558153 - RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula N/A
Completed NCT01927185 - Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation N/A